(Q34656266)

3 August 2017

1 reference

title

Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome (English)

1 reference

3 August 2017

0 references

1 reference

Masashi Narita

1

1 reference

3 August 2017

Brian T Tsuji

series ordinal

2

1 reference

3 August 2017

Victor L Yu

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

3 August 2017

1 reference

3 August 2017

27

1 reference

3 August 2017

8

1 reference

3 August 2017

1189-1197

1 reference

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

3 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Peripheral neuropathy associated with prolonged use of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-induced inhibition of mitochondrial protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-associated toxic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid use associated with lactic acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-induced neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Severe sensory neuropathy associated with long-term linezolid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Severe bilateral optic neuritis associated with prolonged linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid induced toxic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-associated toxic optic neuropathy: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Multi-system Infection with Nocardia farcinica-therapy with linezolid and minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-induced optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-induced lactic acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid and serotonergic drug interactions: a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin syndrome and other serotonergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin toxicity associated with concomitant use of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin syndrome due to co-administration of linezolid and venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid and serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin syndrome and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Serotonin syndrome and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

Linezolid-associated serotonin syndrome: what we can learn from cases reported so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.8.1189

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.8.1189

1 reference

3 August 2017

1 reference